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ABSTRACT:  
Background: Patients in remission/recovery following episodes of Major Depressive Disorder (MDD) 
remain highly vulnerable to future relapse/recurrence. Whilst psychological determinants of this risk 
are well established, little is known about associated biological mechanisms. Recent work has 
implicated the Default Mode Network (DMN) in this vulnerability but specific hypotheses remain 
untested within the high-risk, recovered-state of MDD. Aims: 1) To test the hypothesis that there is 
excessive Default Mode Network (DMN) functional connectivity (FC) during task performance within 
recovered-state MDD; 2) To test for connected DMN cortical gyrification abnormalities. Method: A 
multimodal fMRI/MRI study, including task-based FC and cortical folding analysis, comparing 20 
recovered-state MDD patients with 20 matched healthy controls.  Results: Recovered-state MDD 
patients showed significant task-based DMN hyperconnectivity, associated with hypogyrification of 
key DMN regions (bilateral precuneus). Conclusions: This is the first evidence of connected 
structural and functional DMN abnormalities in recovered-state MDD, supporting recent hypotheses 
on biological-level vulnerability.  
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INTRODUCTION:  
 
Patients who have recovered from episodes of Major Depressive Disorder (MDD) remain highly 
vulnerable to future recurrence. Clinical studies put this risk of further MDD episodes at up to 80% 
(1) in contrast with the general population lifetime risk of 6.7% (2). Whilst psychological 
determinants of this risk are well established (3, 4), relatively little is known about associated 
biological mechanisms. Functional Magnetic Resonance Imaging (fMRI) studies have provided some 
early data on the presence of functional brain abnormalities in recovered-state patients with MDD 
when performing executive tasks (5, 6). However, there remains no published evidence on brain 
network functional connectivity (FC) or related structure in recovered MDD despite credible recent 
hypotheses of their importance. The clearest theory concerns the Default Mode Network (DMN); a 
brain network in which increased levels of activity have well evidenced associations with internally 
focused appraisal (7) and which has therefore been considered a potential neural substrate for the 
ruminative, introspective cognitive patterns of MDD (8-10). The DMN is further implicated through 
convergent findings of increased resting-state FC between specific DMN regions (namely the 
dorsomedial Prefrontal Cortex (dmPFC) and precuneus) in both depressed-state MDD (11) and 
never-depressed, first-degree relatives of patients with recurrent MDD (9); leading the authors of a 
recent review to hypothesise that DMN hyperconnectivity continues within recovered-state MDD, 
persisting  into task-based activity where it acts as a substrate for overly internal processing, 
interfering with the recruitment of more effective networks and ultimately creating biological-level 
vulnerability to depression (10). Recent evidence linking FC and gyrification of the cortical surface 
(12), means we might additionally predict that abnormal DMN FC is associated with abnormal 
gyrification in key DMN regions. In light of this literature, our aims were firstly to test the hypothesis 
that there is excessive task-based DMN FC within recovered-state MDD; and secondly to test the 
hypothesis that there are connected abnormalities in cortical gyrification within anatomical regions 
of the DMN. 
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METHOD: 
 
Recruitment and Clinical assessment: 
The recruitment and assessment of this population has been previously reported in detail (5) but is 
summarised here for convenience. 
Patients were recruited through physician referral from general adult psychiatric clinics in 
Nottingham, UK.  Controls were mainly recruited through posters displayed at a General Hospital 
and a community surgery in Nottingham. Following complete description of the study, written, 
informed, capacitous consent was obtained from all participants. The study was approved by the 
Local Research Ethics Committee. 
All potential recruits underwent an initial psychiatric assessment by senior clinical psychiatrists (NN, 
GW, PL), including a detailed history of personal and family psychiatric/medical disorder, substance 
abuse and medication history;  followed by the Structured Clinical Interview for DSM-IV Axis I 
Disorders (SCID-CV) (13); 2 measures of depressive symptoms, the 17-item Hamilton depression 
rating scale (Ham-D) (14) and the Beck Depression Inventory – II (BDI-II) (15); 2 measures of 
personality, the Short Eysenck Personality Questionnaire-revised (EPQ-R)  (16) and the Personality 
Disorders Questionnaire-version 4 (PDQ-4+)(17); a measure of IQ, the Ammons Quick Test (Quick) 
(18); a measure of cognitive function, the Folstein Mini-Mental State Examination (MMSE)(19); a 
handedness questionnaire (RIC) (20); and a fMRI safety questionnaire.  
A clinical consensus meeting followed initial screening to determine inclusion/exclusion. Minimum 
inclusion for the patient group required at least 2 previous episodes of DSM-IV Major Depression, 
diagnosed through SCID-CV, now in recovered-state (with normalized function for at least 3 months 
and 17-item Ham-D < 8). Exclusion criteria were co-morbid axis I psychiatric disorder (with particular 
focus on misdiagnosed Bipolar II disorder or anxiety disorders); personality disorder; drug or alcohol 
disorder; untreated medical disorder; any previous or current CNS disease; or fMRI safety issues. In 
5 
 
addition to the above criteria, potential controls were excluded if there was evidence of any current 
or past psychiatric disorder. 
Patients were followed up over 1 year for evidence of recurrence, determined through use of the 
SCID-CV at 4-month intervals combined with clinical data from case-notes and treating clinicians.  
Statistical testing of clinical, demographic and behavioural data used SPSS 16.0 
(http://www.spss.com) and applied the significance criterion p <0.05, with equal variances not 
assumed. All t-tests were 2-tailed. 
Image Acquisition: 
BOLD data acquisition: Gradient Echo-Echo Planar Images were acquired using a Philips 3T system 
during 2 separate 10-minute sessions of a Go/NoGo (GNG) paradigm. Following T2* image 
stabilisation, 252 volumes of 36 contiguous descending slices were collected (image matrix 64*64, 
voxel size 3mm*3mm*3mm, field of view 19.2cm, Echo Time 40ms and Repetition Time 2300ms). All 
subjects received standardized preparation aimed at minimizing performance variance and anxiety 
(including scripted explanation, practice sessions of the task and habituation within the scanner).  
The GNG paradigm has been previously reported in detail (5) but is summarised here. Go (x) or No-
Go (k) stimuli were presented on a projected screen for 267ms; inter-stimulus interval was jittered 
and pseudorandom  between 3100–3700 ms, so that each subject had either 159 or 160 stimuli per 
block of which 32 or 33 were No-Go. Subjects were asked to respond as quickly as possible (by a 
single button press) when shown the letter ‘x’ and to withhold response when shown the letter ‘k’. 
The only explicit feedback used during task was the message ‘Too Slow’, shown for correct responses 
to ‘x’ that were delayed beyond an individually calculated time ceiling, derived from response times 
in the pre-fMRI practice sessions.  
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BOLD data Functional Connectivity (FC) analysis:  
First-level analysis: PAR/REC format data from the 3T Philips system were converted to NIfTI format 
using the program dci2nii (http://www.mccauslandcenter.sc.edu/mricro/mricron/dcm2nii) based on 
MRIcron (http://www.mricron.com). The converted images were then pre-processed using DPARSFA 
(http://www.restfmri.net)  (21) based on REST (http://www.restfmri.net) and SPM8 
(http://www.fil.ion.ucl.ac.uk/spm). During pre-processing, images were reoriented, slice timed, 
spatially realigned, co-registered, segmented, normalised and smoothed to 8mm. The fMRI time 
series was then subject to linear detrending and temporal bandpass filtering (0.01 – 0.08 Hz) before 
regressing out motion parameters, global mean signal, white matter signal and cerebrospinal fluid 
signal (aimed at removing spurious fluctuations not involved in specific regional correlations). 
Following methodology validated in task-based FC analysis (22, 23), transformed correlation 
coefficients (z scores) were calculated to generate seed-region based Functional Connectivity z (FCz) 
maps in DPARSFA, based on 8mm radius seeds in the left and right precuneus (essential regional 
components of the DMN, with co-ordinates taken from key published literature (11)). Since the co-
ordinates were initially published in Talairach space, a conversion was made from Talairach to 
Montreal Neurological Institute (MNI) space for the current analysis, using tal2mni (24). For each 
subject FCz maps were generated independently for the left and right DMN seeds, each containing 
the voxelwise Pearson coefficients of the correlation between the time-series of BOLD variations in 
the seed region and the rest of the brain.  
Second-level analysis: This comprised a main analysis, in which single subject FCz maps were entered 
into t-tests, using SPM8, to assess whole-brain significance across-group and between-group 
(Controls vs. Patients); a subsidiary analysis, assessing maintenance-phase medication effects, in 
which single subject FCz maps were entered into one-factor analyses of variance (ANOVAs) with 3 
levels (Unmedicated Patients, Medicated Patients, Controls); and a region of interest (ROI) analysis 
to enable direct comparison of our findings with key literature. The ROI analysis used a small volume 
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correction (SVC) within 12mm radius of bilateral dmPFC regions identified by Sheline et al. as 
uniquely important ‘dorsal nexus’ areas within depressed-state MDD exhibiting increased resting-
state FC to several networks including the DMN (11). All between group tests used age and session 
as covariates of no interest.  
Significance testing: In keeping with Chumbley and Friston 2009 (25), significance testing in our main 
and ROI analysis incorporates spatial extent, reporting clusters surviving correction at PFDR-cor<0.05. 
Voxel-level statistics are additionally reported where appropriate at PFWE-cor<0.05 (e.g. in the case of 
extensive clusters crossing anatomically defined regions). Since cluster-level statistics are not 
provided in SPM8 ANOVA, this part of the subsidiary analysis reports voxel-level PFWE-cor<0.05.  
Reporting of co-ordinates and illustration of clusters: For ease of comparison with existing literature, 
all coordinates have been reported in Talairach space, following conversion from MNI space using 
the program mni2tal (24). Significant clusters have been illustrated with Xjview Version 8.11 
(http://www.alivelearn.net/xjview). 
T1 image Gyrification analysis: 
Surface Extraction: Cortical surfaces were reconstructed using FreeSurfer version 5.1.0 
(http://surfer.nmr.mgh.harvard.edu). Standard procedures were followed, as described by Dale et 
al. (26). Pre-processing used Schaer’s method (27), an extension of Zilles’ gyrification index 
approach(28), to measure cortical folding patterns for each of the several thousands of vertices 
across the entire cortical surface. This automated method provides Local Gyrification Indices (LGIs), 
numerical values assigned in a continuous fashion to each vertex of the reconstructed cortical 
surface. The LGI of a vertex corresponds to the ratio of the surface area of the folded pial contour 
(‘buried’ surface) to the outer contour of the cortex (‘visible’ surface) included within a sphere of 
25mm radius drawn around each vertex, in line with previous studies (26, 28, 29). Thus the LGI value 
at each vertex reflects the amount of cortex buried in its immediate locality. Schaer’s index captures 
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both the spatial frequency and the amount of curvature of cortical folds in the locality of each 
vertex. 
Statistical analysis examining the spatial distribution of group differences in gyrification: A 
vertexwise whole brain analysis was performed to localize brain regions showing the most 
prominent gyrification differences between groups, assessing gyrification on a point-by-point basis 
across the entire brain. The vertex-wise LGI measurement for each subject was mapped on a 
common spherical coordinate system (fsaverage). A general linear model controlling for the effect of 
age and gender was used to compute differences in gyrification between the groups for the right 
and left hemispheric surfaces, in keeping with published literature (29, 30). The FreeSurfer version 
5.1.0 Query Design Estimate Contrast (QDEC) tool was used to generate between-group contrasts. 
To correct for multiple testing we used a permutation method with 10,000 simulations and 
identified clusters that survived a type 1 error rate of 5% at a cluster inclusion threshold of p=0.05 
(two-tailed). Reported results are corrected for age and gender (including intracranial volume (ICV) 
as a covariate in the model did not make any important or significant difference to these results).  
To test for spatial overlap in the DMN nodes used in our FC analysis (right and left precuneus) and 
regions showing prominent gyrification defects,  we used mri_vol2surf option in FreeSurfer to 
project these DMN nodes onto the reconstructed average cortical surface (fsaverage), alongside the 
clusters that emerged as significant in the vertexwise whole brain gyrification analysis.  
RESULTS: 
Subjects, clinical and behavioural data:  
The demographic and clinical data have been previously reported in detail (5) but are summarized 
here and in Table 1. 
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Forty-two individuals (20 patients and 22 controls) met the minimum inclusion/exclusion criteria and 
hence were recruited.  Complete T2* images sensitive to BOLD contrast were collected for 20 
patients and 20 matched controls (the first 2 control subjects were excluded due to technical 
difficulties with image acquisition).  
Demographic data indicated that the control and patient groups were well matched for age (range: 
24 – 63), gender, IQ and laterality. The MDD group showed high recurrence (mean of 4 episodes) but 
were in stable recovery at the time of data acquisition (mean 13 months).  
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Behavioural data: Paired across-group t-tests (n=40) showed significantly faster reaction times (RTs) 
for error commission trials vs. correct response trials (t =7.11, df=39, p<0.001) in keeping with the 
literature (31, 32); and significant slowing across-group in RTs for correct response trials following 
error commission (t=6.37, df=39,  p<0.001), again in keeping with the literature (33). There were no 
significant between-group (controls vs. patients) behavioural differences. 
Main Task-based Functional Connectivity (FC) analysis (whole-brain level):  
Across-group (n=40) findings: As expected positive and negative FC patterns were very similar for 
the two DMN seed regions in the right and left precuneus (illustrated using results from the right 
precuneus seed in Figure 1). Thresholded at t=5.23, with clusters surviving PFDR-cor<0.05 (and voxels 
surviving voxel-level PFWE-cor<0.05), regions of significant positive FC included bilateral precuneus and 
posterior cingulate cortex (BA31); bilateral anterior cingulate cortex (BA 10, 32, 24); bilateral medial 
prefrontal cortex (BA10); bilateral temporal cortex (BA21); and bilateral posterior parietal cortex 
(BA40). Regions of significant negative FC included bilateral supplementary motor area (BA6); 
bilateral inferior orbitofrontal cortex (BA11); bilateral anterior insula; bilateral precentral gyrus 
(BA9); and bilateral dorsolateral prefrontal cortex (BA10). These results are consistent with the 
literature (8). 
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FIGURE 1: Across-group (n=40), whole-brain significant clusters (thresholded at T=5.23, equivalent to 
voxel-level FWE-corr <0.05) displayed in transverse slice view on a 152 T1 template (xjview), showing 
significant positive functional connectivity (red, yellow, green) and negative functional connectivity 
(blue) with the right precuneus (DMN) seed (7, -60, 21). Figures in the legend represent t values; 
figures adjacent to transverse slices are z values. 
 
 
Between-group findings: At corrected whole-brain cluster-level PFDR-cor<0.05 there was significantly 
greater FC for MDD > Controls from both right and left precuneus seeds to clusters in the right 
dmPFC (BA9) with some extension into dorsal regions of the right frontal pole (BA10) (statistics given 
in Table 2). There was also some evidence of increased FC (MDD > controls) to clusters in the left 
dmPFC (BA9), when thresholded at p <0.001, but this did not survive subsequent whole-brain 
correction (strongest from the right precuneus seed for MDD > Controls, cluster extent 20 voxels, 
cluster-level PFDR-corr=0.054 with peak voxel T=4.85 at -24, 34, 43). These findings are illustrated in 
Figure 2. There were no cluster-level significant findings for controls > patients. 
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FIGURE 2: Rendered images (xjview) of functional connectivity from the left and right precuneus 
(DMN) seeds for Patients > Controls, thresholded at p <0.001 uncorrected, cluster size > 5 voxels. All 
right cortical clusters shown here survived subsequent correction at cluster-level PFDR-cor<0.05; left 
cortical clusters did not survive correction at this level. The superimposed red outline on the right 
lateral view indicates the most consistent finding of whole-brain significant hyperconnectivity from 
both left and right precuneus (DMN) seeds to an overlapping area of dmPFC (BA9), also significant 
within a small volume correction of the right ‘dorsal nexus’ described by Sheline et al. 2010. 
 
Table 2. Whole-brain significant functional connectivity from Right and Left precuneus (DMN) seeds 
(+/-7, -60, 21; from Sheline et al. 2010); reporting statistics where whole-brain, cluster-level P survived FDR-
corr <0.05.  
 Cluster 
(voxels) 
Region 
(BA) 
Cluster-level 
P 
(FDR-corr) 
Peak 
T 
Stat. 
Peak 
Z 
Stat. 
Peak 
Coordinates 
(x, y, z) 
  MDD > Controls       
    Right DMN seed   
  Right dmPFC 45 9      0.001 4.45 4.18 30, 40, 34 
     Left DMN seed       
   Right dmPFC 27 9      0.025 4.46 4.19 30, 40, 34 
 25 10 0.025 4.57 4.28 21, 56, 14 
  Controls > MDD       
     Nil   
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Subsidiary Analysis of Medication Status (Whole-brain level Task-based FC):  
Three-group ANOVAs using medicated (n=14), unmedicated (n=6) and control (n=20) groups 
investigated the effect of continuing maintenance-phase antidepressant medication (detailed in 
subsidiary material S1) on FC. ANOVA of left precuneus seed FC showed significant main effect of 
group within a right dmPFC cluster (peak at 30, 36, 39 F2-75 =17.44, PFWE-corr=0.042). Follow-up t-tests, 
inclusively masked for main effect of group at p<0.001, were significant for Unmedicated patients > 
Controls at whole-brain level (cluster extent 28 voxels, cluster-level PFDR-corr=0.021, peak T=5.85 at 30, 
36, 39). ANOVA of right precuneus seed FC showed main effect that approached significance in the 
same right dmPFC region (peak at 30, 36, 39 F2-75 =16.60, PFWE-corr=0.075) and given the importance of 
exploring potential bias through medication follow-up t-tests were performed, masked for main 
effect of group at p<0.001, showing whole-brain significance for Unmedicated patients > Controls 
(cluster 33 voxels, cluster-level PFDR-corr=0.006, peak T=5.76 at 30, 36, 39). Figure 3 depicts these main 
between-group findings, using extracted data from 12mm radius spheres centered on the peak voxel 
for main effect within the 3-group ANOVAs. 
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FIGURE 3: Functional connectivity between precuneus (DMN) seeds (Red for Right, Green for Left) 
and the right dmPFC (30, 36, 39), for unmedicated, medicated and control groups, using extracted 
data from 12mm radius spheres centered on the peak voxel for main effect within the 3-group 
ANOVA (with error bars indicating 95% confidence intervals). 
 
Prospective follow-up of the recovered MDD patient cohort showed that positive medication status 
was associated with significantly reduced 1-year relapse (RR=0.29, 95% CI 0.10–0.85).  
Region of Interest (ROI) Task-based FC analysis:  
A separate ROI analysis assessed the proximity of our whole-brain dmPFC findings to specific 
bilateral dmPFC ‘dorsal nexus’ regions from the literature (left ROI -24, 35, 28; right ROI 18, 34, 29) 
(11). Results of this ROI analysis are presented in Table 3, showing significantly increased task-based 
FC, surviving cluster-level correction PFDR-cor<0.05,  between bilateral precuneus regions and clusters 
within a 12 mm radius sphere centred on the bilateral dmPFC ‘dorsal nexus’ regions. 
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Gyrification analysis:  
There was significant bilateral hypogyrification (cluster-wise p<0.001, permutation corrected for 
multiple testing, cluster inclusion threshold p=0.05, n=10,000) in the patient group extending across 
bilateral medial surface regions incorporating the precuneus. Additionally there was 
hypergyrification (cluster-wise p<0.001, permutation corrected for multiple testing, cluster inclusion 
threshold p=0.05, n=10,000) in patients in a more anterior region incorporating the left anterior 
cingulate cortex. These results are illustrated in figure 4. 
To assess the effect of medication in this gyrification analysis we compared medicated and 
unmedicated patients at the lenient statistical threshold of p=0.10 but did not detect any significant 
differences. The results of this analysis were unaffected when re-analysed using ICV as an additional 
covariate.  
 
Table 3. Showing significant between group functional connectivity differences for bilateral 
precuneus (DMN) seeds (+/-7, -60, 21; Sheline et al. 2010); reporting clusters surviving FDR-corr <0.05 
within 12mm small volume correction of the bilateral dmPFC ‘dorsal nexus’ regions (Sheline et al. 2010). 
 Cluster 
(voxels) 
Region 
(BA) 
Cluster-level 
P 
(FDR-corr) 
T 
Stat. 
Z 
Stat. 
Coordinates 
(x, y, z) 
MDD > Controls 
Right Precuneus 
  
 
   
Right dmPFC 20 9      0.002 4.10* 3.88 24, 39, 28 
Left Precuneus       
Right dmPFC 10 9 0.040 4.04* 3.83 27, 36, 29 
Left dmPFC 15 9      0.006 3.70* 3.70 -21, 31, 29 
       
Controls > MDD       
 Nil      
       
 *: Voxel-level significance PFWE-corr<0.05 
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FIGURE 4: Depiction of whole-brain significant findings from the Gyrification analysis, showing 
significant (p<0.001) bilateral precuneus hypogyrification (yellow); and hypergyrification (blue) 
within the left dorsal and rostral anterior cingulate cortex for the patient group compared to 
controls. Figures in the legend represent T values. The circular Regions of Interest (indicated in red 
outline) depict the left precuneus DMN seed used in our functional connectivity analysis (taken from 
Sheline et al.) and a part of Sheline et al.’s ‘dorsal nexus’.  
 
As shown in Figure 4, the left precuneus hypogyrification incorporated the precuneus (DMN) seed 
used in our FC analysis and originally identified by Sheline et al. (11). Additionally, we mapped 
Sheline et al.’s left ‘dorsal nexus’ (-24, 35, 28 spherical ROI of 12mm radius) onto the inflated surface 
to study the overlap with the gyrification maps. The BA32 part of ‘dorsal nexus’ (but not the BA8 or 
BA 9 areas) showed an overlap with the hypergyric ACC cluster identified here. Task-based FC 
analysis based on this hypergyric ACC cluster (presented in supplementary material S2) identified 
only one significant finding, of hyperconnectivity for controls > patients within a left posterior 
tempero-parietal area (cluster 33 voxels, Cluster-level PFDR-corr=0.005, peak T=4.24 at -45, -48, 27). 
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DISCUSSION:  
Our data provide the first direct evidence of task-based DMN hyperconnectivity within recovered-
state MDD, confirming a recently published hypothesis (10). This adds to resting-state FC evidence 
from depressed-state MDD (11) and never-depressed, high vulnerability cohorts (9), supporting the 
idea that DMN hyperconnectivity is a core feature of the highly recurrent disorder of MDD, 
extending across different states into apparent clinical recovery. Viewed as a biological substrate, 
the persistence of DMN hyperconnectivity into recovery is consistent with well-established 
psychological models that have long identified the persistence of psychological-level risk factors into 
recovered-state MDD (34). More specifically because of its association with internal focus, DMN 
hyperconnectivity is a plausible substrate for rumination, observed across states of MDD and 
described by Beck as involving disproportionate allocation of resources from, ‘the external 
environment to internal experiences’ (34). At a brain network level, ‘the interference hypothesis’ 
holds that persistence of relatively high DMN connectivity into task interferes with adaptive 
switching to more appropriate goal oriented brain networks (35). More recently there have been 
indications that these networks overlap to an unusual degree within MDD (reviewed in (10)) and 
that the most robustly identified hub in our task-based DMN analysis (right dmPFC, BA9) acts as a 
‘dorsal nexus’, strongly connected to several networks within the depressed-state of MDD (11). 
Since we have previously shown event-related fMRI hypoactivity within this right ‘dorsal nexus’ 
region during active processing (e.g. of error commission) in recovered-state MDD (5), then invoking 
the ‘interference hypothesis’ (35) supports the proposition that within recovered-state MDD 
persistent excessive DMN activity during task, most prominently involving the right ‘dorsal nexus’, 
interferes with capacity to appropriately switch this dmPFC (BA9) region to its role in more ‘task 
positive’ (active) networks; resulting in cognitive and attentional bias that increases the risk of 
depression.  
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The FC findings were associated with bilateral hypogyrification incorporating the precuneus, broadly 
consistent with the only previous MDD gyrification study that we are aware of, which did not 
incorporate a FC analysis but demonstrated hypogyrification in a depressed-state MDD cohort 
extending bilaterally into posterior cingulate/precuneus areas (36). Our data extend this finding by 
identifying a link between hypogyrification of key DMN hubs (bilateral precuneus) and task-based 
DMN hyperconnectivity in the recovered MDD group (20 patients vs. 20 controls). In attempting to 
understand the directionality of this association, we can draw on limited recent evidence from 
multimodal work in schizophrenia, showing a link between regional hypergyrification and reduced 
long range FC (12), consistent with the converse finding here of hypogyrification associated with 
increased long range FC (between the precuneus and dmPFC in the MDD patient group); and also 
consistent with the FC analysis based on MDD group ACC hypergyrification (associated with 
relatively reduced long range FC in patients). Since the ACC has been viewed in recent literature as 
part of a salience network (37), distinct from the DMN, the increased FC in controls between the left 
ACC and left tempero-parietal regions involved in external cue processing (including speech) could 
potentially have a functional advantage through enhanced environmental awareness.  
Limited evidence from our subsidiary analyses showed no apparent effect of medication status on 
DMN node gyrification (i.e. significant precuneus hypogyrification was only observed when 
comparing the whole patient group against controls); but a significant association between 
medication status and task-based FC, consistent for bilateral precuneus seeds and producing an 
apparently stratified effect (shown in Figure 3). Whilst we must remain cautious, since one of the 
groups was small (n=6), the results do at least raise the possibility of a relatively stable structural 
disruption involving key DMN nodes (observable in significant hypogyrification for the whole patient 
group vs. controls, without apparent medication status effects), linked to relatively modifiable task-
based DMN hyperconnectivity (associated with significant medication status effects). In this case 
DMN gyrification and connectivity patterns might be thought of as different biological levels of MDD 
19 
 
vulnerability, with the former potentially related to early disruptive effects of trauma on structural 
aspects of DMN development (8) within the main period of gyrus formation (38).  
Limitations: We acknowledge the potential bias introduced by maintenance-phase antidepressant 
medication in the MDD group. However, additional targeted analyses did not find any association 
between either task-based FC or gyrification and positive medication status. Indeed, where there 
was any association with medication status (in task-based FC), this was most abnormal (from both 
DMN seeds) in patients who had stopped maintenance-phase medication prior to scanning. 
Although we could not find any indication that maintenance-phase antidepressant medication 
caused the observed differences in DMN FC or gyrification, we should remain cautious that this part 
of the analysis (relying on relatively small groups) may have been underpowered to detect real 
differences.  
Additionally, we have presented a seed-region DMN FC analysis using task-based data, following on 
from extensive literature indicating the validity of this approach, (e.g. (22, 23, 39)), and evidence of 
persisting, though relatively attenuated DMN activation during a range of tasks, including externally 
focused activity (39, 40). Although this approach has been shown to provide qualitatively similar 
results to the analysis of resting-state FC data, caution should be exercised in the quantitative 
differences that may exist between these approaches (39). This issue is likely to be most problematic 
when making within-group task-based vs. resting-state FC comparisons and should be much less 
problematic in the analysis presented here, where we made a between-group comparisons focused 
purely on task-based DMN FC (i.e. not making experimental comparisons with resting-state). We 
should also remain conscious of this issue in considering resting-state and task-based studies from 
the literature; different approaches that often retain mutual relevance, as here (9, 11). 
Strengths: We present the first data on DMN connectivity (task-based) in recovered-state MDD and 
provide the first multimodal analysis relating FC findings in MDD to cortical gyrification. These data 
test a specific and important hypothesis coming out of the MDD literature.  
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Implications: Within apparent clinical recovery from MDD there are significant and apparently linked 
abnormalities in DMN structure (identified through hypogyrification of key hubs) and function 
(identified through task-based DMN hyperconnectivity). These new findings strengthen our 
knowledge of the biological-level vulnerability to MDD by confirming and extending an important 
hypothesis (10) based on previous research (9, 11). When assessed alongside event-related fMRI 
evidence (5), it seems possible that the identified task-based DMN hyperconnectivity may interfere 
with switching of important dmPFC areas to more appropriate task-positive activity, in line with 
earlier theories (35). Further research is needed to confirm the more limited findings that DMN 
functional hyperconnectivity is greatest in MDD patients who have discontinued maintenance-phase 
medication; and the theory that this networked brain activity may represent a more dynamic 
indicator of MDD vulnerability linked to relatively stable cortical gyrification abnormalities. 
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